Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 598-605

  Sitges, María ^a   Chiu, Luz María ^a   Guarneros, Araceli ^a   Nekrassov, Vladimir ^b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

Antiepileptic drug; Epilepsy; Synaptosome; Veratridine

Indexed keywords

CARBAMAZEPINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; LAMOTRIGINE; NEUROTRANSMITTER; OXCARBAZEPINE; PHENYTOIN; SODIUM CHANNEL; SODIUM ION; TOPIRAMATE; TRITIUM; VINPOCETINE;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; HIPPOCAMPUS; ION PERMEABILITY; MALE; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC POTENTIAL; SYNAPTOSOME;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE ENDINGS; RATS; RATS, WISTAR; SODIUM CHANNELS; TRITIUM;

EID: 33846487961     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.09.002     Document Type: Article

References (43)

1. Ambrosio A.F., Silva A.P., Araujo I., Malva J.O., Soares-da-Silva P., Carvalho A.P., and Carvalho C.M. Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels. Eur. J. Pharmacol. 406 (2001) 191-201
2. Bhatti J.Z., and Hindmarch I. Vinpocetine effects on cognitive impairments produced by flunitrazepam. Int. Clin. Psychopharmacol. 2 (1987) 325-331
3. Bonifacio M.J., Sheridan R.D., Parada A., Cunha R.A., Patmore L., and Soares da Silva P. Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine. Epilepsia 42 (2001) 600-608
4. Brunbech L., and Sabers A. Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs 62 (2002) 593-604
5. Cheung H., Kamp D., and Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13 (1992) 107-112
6. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr. Top. Med. Chem. 5 (2005) 3-14
7. Deffois A., Fage D., and Carter C. Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci. Lett. 220 (1996) 117-120
8. + channels in hippocampal mossy fiber boutons. Neuron 45 (2005) 405-417
9. Galindo C., and Sitges M. Dihydropiridines mechanism of action in striatal isolated nerve endings. Comparison with -agatoxin IVA. Neurochem. Res. 29 (2004) 659-669
10. + induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem. Res. 29 (2004) 347-355
11. Gates J.R. Side effect profiles, behavioral consequences of antiepileptic medications. Epilepsy and Behavior 1 (2000) 153-159
12. Hindmarch I., Fuchs H.H., and Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int. Clin. Psychopharmacol. 6 (1991) 31-43
13. Krueger B.K., Blaustein M.P., and Ratzlaff R.W. Sodium channels in presynaptic nerve terminals. Regulation by neurotoxins. J. Gen. Physiol. 76 (1980) 287-313
14. Kwan P., and Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357 (2001) 216-222
15. Leach M.J., Marden C.M., and Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27 (1986) 490-497
16. 2+ channels, and GABA(A) receptors. Br. J. Anaesth. 90 (2003) 199-211
17. Macdonald R.L., and McLean M.J. Anticonvulsant drugs: mechanisms of action. Adv. Neurol. 44 (1986) 713-736
18. McLean M.J., Bukhari A.A., and Wamil A.W. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia 41 (2000) S21-S24
19. Nekrassov V., and Sitges M. Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo. Epilepsy Res. 60 (2004) 63-71
20. Nekrassov V., and Sitges M. Additive effects of antiepileptic drugs and pentylenetetrazole on hearing. Neurosci. Lett. 406 (2006) 276-280
21. 2+ release in rat optic nerve during in vitro chemical ischemia. J. Neurosci. 25 (2005) 9960-9967
22. Parada A., and Soares da Silva P. The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine. Neurochem. Int. 40 (2002) 435-440
23. Prevey M.L., Delaney R.C., Cramer J.A., and Mattson R.H. Complex partial and secondarily generalized seizure patients: cognitive functioning prior to treatment with antiepileptic medication. VA Epilepsy Cooperative Study 264 Group. Epilepsy. Res. 30 (1998) 1-9
24. 3H]GABA release. Neurochem. Res. 21 (1996) 889-895
25. + channel effects of remacemide and desglycinyl-remacemide in rat cortical synaptosomes. Eur. J. Pharmacol. 438 (2002) 63-68
26. Schmidt D. The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy. Res. 50 (2002) 21-32
27. Sitges M. Effect of organic and inorganic calcium channel blockers on σ-amino-n-butyric acid release induced by monensin and veratrine in the absence of external calcium. J. Neurochem. 53 (1989) 436-441
28. 3H]GABA from synaptosomes. Neurochem. Res. 20 (1995) 1065-1071
29. 2+ and glutamate release in depolarised brain nerve terminals. Neurochem. Int. 46 (2005) 53-60
30. Sitges M., and Nekrassov V. Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation. Neurochem. Res. 24 (1999) 1585-1591
31. Sitges M., and Nekrassov V. Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. Clin. Neurophysiol. 115 (2004) 2711-2717
32. Sitges M., and Reyes A. Effects of verapamil on the release of different neurotransmitters. J. Neurosci. Res. 40 (1995) 613-621
33. Sitges M., Peña F., Chiu L.M., and Guarneros A. Study on the possible involvement of protein kinases in the modulation of brain presynaptic sodium channels; comparison with calcium channels. Neurochem. Int. 32 (1998) 177-190
34. Sitges M., Nekrassov V., and Guarneros A. Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Brain Res. 854 (2000) 48-56
35. Sitges M., Galván E., and Nekrassov V. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes. Neurochem. Int. 46 (2005) 533-540
36. Subhan Z., and Hindmarch I. Psychopharmacological effects of vinpocetine in normal healthy volunteers. Eur. J. Clin. Pharmacol. 28 (1985) 567-571
37. + current fractions by the new anticonvulsant topiramate. J. Pharmacol. Exp. Ther. 288 (1999) 960-968
38. Trejo F., Nekrassov V., and Sitges M. Characterization of vinpocetine effects on DA and DOPAC release in striatal isolated nerve endings. Brain Res. 909 (2001) 59-67
39. Waldmeier P.C., Baumann P.A., Wicki P., Feldtrauer J.J., Stierlin C., and Schmutz M. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45 (1995) 1907-1913
40. Wamil A.W., Schmutz M., Portet C., Feldmann K.F., and McLean M.J. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur. J. Pharmacol. 271 (1994) 301-308
41. Wang S.J., Shira T.S., and Gean P.W. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 12 (2001) 2255-2258
42. 3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol. 22 (1982) 627-635
43. Zona C., Ciotti M.T., and Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231 (1997) 123-126